Biotech & pharma
New microscope decodes complex eye circuitry
11 Mar 2011
Nanoparticles increase survival after blood loss
02 Mar 2011
New marker found for Sanfilippo disease
By By Scott LaFee | 02 Mar 2011
Certain parts of the brain activated in people who heard tailored health messages and quit smoking
01 Mar 2011
Missing Molecule Raises Diabetes Risk in Humans
28 Feb 2011
Brain function linked to birth size in new study
25 Feb 2011
Research reveals that children who were born small, with relatively large placentas, showed more activity on the right side of their brains than the left — a pattern of brain activity linked with mood disorders such as depression
Microbubbles to light the way to sentinel lymph nodes of breast cancer patients
By By Daniel Kane | 24 Feb 2011
Rare surgery gives man two hearts beating as one
By By Kim Edwards | 19 Feb 2011
After a rare, life-saving cardiac surgery called heterotopic heart transplantation, this Valentine’s Day, Tyson Smith woke up with two beating hearts – his old failing heart and a newly transplanted one.
Study sheds light on RNA “on / off switches”
17 Feb 2011
Searching for the soul of the genome
By By Scott LaFee | 12 Feb 2011
Computer simulations revealthe structure and dynamics of chemical signal that triggers metastatic cancer
By By Warren Froelich | 09 Feb 2011
Brain can learn to overcome sleep apnea: scientist
By By Mike Kennedy | 09 Feb 2011
Cannabis link to psychosis revealed
By By Mike Kennedy | 09 Feb 2011
The first ever meta-analysis of more than 20,000 patients shows that smoking cannabis is associated with an earlier onset of psychotic illness by up to 2.7 years
The hitch in the drug? the itch in the drug
By By Scott LaFee | 09 Feb 2011
Nicotinic acid blocks immune cells in atherosclerosis
08 Feb 2011
New findings suggest that nicotinic acid not only alters cholesterol levels, but also has a direct anti-inflammatory effect on atherosclerotic vascular walls
Fluorescent peptides help nerves glow in surgery
By By Scott LaFee | 08 Feb 2011
DNA caught rock 'n rollin'
07 Feb 2011
New techniques for stapling peptides could spur development of drugs for cancer, other diseases
07 Feb 2011
Schizophrenia Gene Mutation Found; Target for New Drugs
By By Scott LaFee | 04 Feb 2011
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation